Finance

Lists
3920:FRA
Spyre Therapeutics Inc
€79.00
-0.63%
(-0.50) 1D
Aug 28, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3920...
Open
€79.00
High
€79.00
Low
€79.00
Mkt. cap
7.97B
Avg. vol.
24.00
Volume
0.00
52-wk high
€92.50
52-wk low
€12.30
No. of employees
125
Open
€79.00
High
€79.00
Low
€79.00
Mkt. cap
7.97B
Avg. vol.
24.00
Volume
0.00
52-wk high
€92.50
52-wk low
€12.30
No. of employees
125
News stories
From web sources and news partners
About Spyre Therapeutics Inc
CEO-
Employees125
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitespyre.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
45.25M
44.64M
60.41M
65.50M
Cost of revenue
45.25M
44.64M
60.41M
65.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.64M
12.53M
15.23M
16.14M
Operating expense
11.64M
12.53M
15.23M
16.14M
Total operating expenses
56.89M
57.17M
75.64M
81.64M
Operating income
-56.89M
-57.17M
-75.64M
-81.64M
Other non operating income
40.33M
-12.50M
-30.36M
-4.61M
EBT including unusual items
-11.18M
-62.53M
-69.00M
-36.20M
EBT excluding unusual items
-11.18M
-62.53M
-99.00M
-76.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.18M
-62.53M
-69.00M
-36.20M
Net profit margin
-
-
-
-
Earnings per share
-0.15
-0.74
-0.74
-0.36
Interest and investment income
5.38M
7.14M
7.00M
10.05M
Interest expense
-
-
-
-
Net interest expenses
5.38M
7.14M
7.00M
10.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-30.00M
-40.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps